Chargement en cours...
Glucose-lowering therapy in type 2 diabetes: New hope after the EMPA-REG outcome trial
Prevention of cardiovascular morbidity and mortality remains the key factor in the treatment of type 2 diabetes (T2DM). In the early phase of T2DM, multifactorial intervention is mandatory and glucose levels should be near normal, in particular in younger patients presenting with the highest cardiov...
Enregistré dans:
| Publié dans: | Herz |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Medizin
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839058/ https://ncbi.nlm.nih.gov/pubmed/27071968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00059-016-4427-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|